OnKure Therapeutics, Inc. OKUR Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -74.4%— | —— | —— | —— | |
| Liquidity | |||||
| Current ratio | 10.3×-0.5× | 10.7×+6.1× | 4.6×-10.3× | 14.9×-9.9× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×— | —— | —— | |
| Per Share | |||||
| Book value per share | $4.16-86.2% | $30.12+108% | -$358.83-16,053% | -$2.22-127% | |
| Valuation | |||||
| Market capitalization | $184.2M+72.6% | $361.23M— | —— | —— | |
| Price / book | 1×-0.4× | 3.5×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do OnKure Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.